Hideki Aizaki - Infectious Diseases

Author Information

Hideki Aizaki is a distinguished researcher affiliated with the Department of Virology II at the National Institute of Infectious Diseases located in Toyama, Shinjuku-ku, Tokyo, Japan. His work primarily focuses on virology, with significant contributions to the study of hepatitis viruses and other infectious diseases.

Research Contributions

Hideki Aizaki has made substantial contributions to the field of virology, with a focus on hepatitis B, C, and D viruses, as well as other pathogen-related research. Notable studies include investigations into the inhibition mechanisms of hepatitis viruses, development of vaccines against hepatitis C, and the role of APOBEC3B in viral mutagenesis. His research also covers the effects of viral infections on the human body, such as the impact of gut dysbiosis during hepatitis A infection in HIV patients and transcriptomic changes in liver cells post-hepatitis C eradication.

Aliases

Hideki Aizaki is also known by the aliases H Aizaki and H. Aizaki in various publications and academic references.

Publication and Citation Metrics

Metric	Value
Total Citations	6152
H-index	42
Number of Papers	137

Publications:

Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses

DOI: 10.3390/v14040764

Year: 2022

Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccine.

DOI: 10.1016/j.antiviral.2022.105266

Year: 2022

Interferon-gamma induced APOBEC3B contributes to Merkel cell polyomavirus genome mutagenesis in Merkel cell carcinoma.

DOI: 10.1016/j.jid.2021.12.019

Year: 2021

Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus

DOI: 10.3390/v13102101

Year: 2021

Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus.

DOI: 10.1016/j.bbrc.2021.06.022

Year: 2021

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

DOI: 10.1007/s12072-021-10269-5

Year: 2021

NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization

DOI: 10.1128/JVI.00938-21

Year: 2021

Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.

DOI: 10.1093/carcin/bgab014

Year: 2021

Investigation of the effects of urea cycle amino acids on the expression of ALB and CEBPB in the human hepatocellular carcinoma cell line FLC-4

DOI: 10.1007/s13577-020-00383-1

Year: 2020

MCPIP1 reduces HBV-RNA by targeting its epsilon structure

DOI: 10.1038/s41598-020-77166-z

Year: 2020

How Important is International Collaboration?

What are the Potential Complications of Strep Throat?

How do Viruses Cause Disease?

What are the Challenges in Studying Parasite DNA?

What are Serological Tests?

Why are Chest CT Scans Important in Infectious Diseases?

What Role Do Viruses Play in Infectious Diseases?

What is the future of DAAs in infectious disease management?

Why are travel precautions important?

What is Plasmodium falciparum?

Partnered Content Networks

Relevant Topics